Analystreport

Horizon Therapeutics PLC (NASDAQ: HZNP) was given a new $35.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report